× Privacy PolicyTerms And Conditions
Subscribe To Our Newsletter

BioMarin CEO: Study results for hemophilia gene treatment are as good as we could hope


Jean-Jacques Bienaime, CEO and chairman of BioMarin Pharmaceutical, appeared on Tuesday's episode of "Mad Money," discussing trial results for the company's hemophilia gene therapy.


By: CNBC Television
Title: BioMarin CEO says study results for hemophilia gene therapy are as 'good as we could hope'
Sourced From: www.youtube.com/watch?v=-gXLEUuwwJc

Read More

Did you miss our previous article...